Xalles Announces Q2 2023 Results and Expands Portfolio With Trio of Strategic Acquisitions

Rhea-AI Summary

Xalles Holdings Inc. - XALL - reports 21% increase in Q2 2023 revenue, reaching $4,708,947, and a 12% rise in net profit. The company achieved 8 consecutive quarters of record revenues, driven by recent acquisitions and strategic investments in Appy Perks, Patient Healthcare Solutions, and Adaptive Analytics. CEO Thomas Nash emphasizes the focus on disruptive innovations, recurring revenue, and asset appreciation, aiming to generate value for stakeholders.

Positive

• 8 consecutive quarters of record revenues demonstrate consistent financial growth
• Strategic acquisitions and investments in Appy Perks, Patient Healthcare Solutions, and Adaptive Analytics position the company for future financial success
• CEO's commitment to generating value for stakeholders through disruptive innovations and recurring revenue

Negative

• None.

WASHINGTON, DC, Aug. 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Xalles Holdings Inc., a premier fintech holding company specializing in cutting-edge technology and financial services solutions, today announced its financial performance for the second quarter ending June 30, 2023. This quarter marked a streak of 8 consecutive quarters of record revenues for the company.

For the second quarter of 2023, Xalles Holdings reported total revenue of $4,708,947, marking a significant 21% increase over Q1. The company's net profit stood at $728,249, reflecting a 12% increase from the previous quarter. This robust growth is largely attributable to the evolution of entities acquired earlier this year and last year. Additionally, the company expects its Q2 acquisitions to further bolster the financial metrics in the latter half of 2023 and into subsequent years.

Alongside these financial achievements, Xalles Holdings made three strategic acquisitions during Q2. The company welcomed Appy Perks, Inc. to the Xalles Commerce business group and Patient Healthcare Solutions, Inc. to the Xalles Health business group as wholly owned subsidiaries. Furthermore, Xalles initiated a strategic investment in Adaptive Analytics, Inc., acquiring a 25% stake within the Xalles Technology business group. The second closing is planned to acquire the remaining 75% stake.

Mr. Thomas Nash, CEO of Xalles Holdings, commented, "Our unique business model – which emphasizes the acquisition, alignment, growth, and eventual spin-off of high-potential fintech ventures – continues to drive our progress. With a focus on disruptive innovations, recurring revenue generation, and the promise of significant asset appreciation, we remain steadfast in our commitment to generating value for all stakeholders."

As Xalles Holdings forges ahead into the second half of the year, it remains dedicated to its growth strategy. The company will continue to collaborate with its current subsidiaries, simultaneously exploring further acquisition opportunities from its target list, with the goal of fortifying its existing business segments and enhancing financial performance.

About Xalles Holdings Inc. (OTC: XALL)

Xalles Holdings Inc. is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places emphasis on leveraging blockchain and other technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams. For more information visit: Xalles.com. 

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.

Investor Relations Contact:
IR@xalles.com
Xalles.com
IR: 202.779.1460

FAQ

What was Xalles Holdings Inc.'s total revenue for Q2 2023?

Xalles Holdings Inc. reported a total revenue of $4,708,947 for the second quarter of 2023.

What is the net profit of Xalles Holdings Inc. for Q2 2023?

Xalles Holdings Inc. achieved a net profit of $728,249 for the second quarter of 2023.

What strategic acquisitions did Xalles Holdings Inc. make during Q2?

Xalles Holdings Inc. welcomed Appy Perks, Inc. and Patient Healthcare Solutions, Inc. as wholly owned subsidiaries, and initiated a strategic investment in Adaptive Analytics, Inc.

What is the CEO's focus for Xalles Holdings Inc.?

CEO Thomas Nash emphasizes a focus on disruptive innovations, recurring revenue generation, and significant asset appreciation to generate value for stakeholders.